Study guide

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies

Key Takeaways Explain This Topic AI

Microcytic anemias (MCV < 80 fL) require iron panel evaluation: serum ferritin < 30 ng/mL confirms Iron Deficiency Anemia (IDA), whereas elevated ferritin (> 300 ng/mL) and low TIBC (< 250 µg/dL) indicate Anemia of Chronic Disease (ACD).

Hemoglobin electrophoresis demonstrating HbA2 > 3.5% confirms beta-thalassemia minor, while alpha-thalassemia trait presents with microcytosis, normal iron parameters, and normal HbA2/HbF levels on electrophoresis.

Sideroblastic anemia is characterized by ringed sideroblasts (≥ 15% on Prussian blue stain), elevated serum iron, and high transferrin saturation (> 50%), commonly caused by lead poisoning or isoniazid-induced vitamin B6 deficiency.

Normocytic anemias (MCV 80–100 fL) are differentiated by Reticulocyte Index (RI): RI > 2% indicates peripheral destruction or hemorrhage (hemolytic anemia, acute blood loss), whereas RI < 2% signifies hypoproliferative bone marrow failure (aplastic anemia, chronic kidney disease).

Macrocytic anemias (MCV > 100 fL) are split into megaloblastic (neutrophil hypersegmentation with ≥ 5 lobes in > 5% of PMNs) due to vitamin B12 or folate deficiency, and non-megaloblastic (alcoholism, liver disease, hypothyroidism); serum methylmalonic acid (MMA) > 0.4 µmol/L specifically distinguishes B12 deficiency from folate deficiency.

Last updated: July 2026

Diagnostic Framework for Anemia

Evaluation of anemia on USMLE Step 2 CK begins with the Mean Corpuscular Volume (MCV) to categorize red blood cell (RBC) size into microcytic (< 80 fL), normocytic (80–100 fL), or macrocytic (> 100 fL). Once MCV is established, clinical history, peripheral blood smear, reticulocyte response, and targeted biochemical assays narrow the differential diagnosis.

To evaluate bone marrow response, the raw reticulocyte percentage must be converted to the Reticulocyte Index (RI) (also called Corrected Reticulocyte Count): RI = Reticulocyte % × ( Patient Hct Normal Hct (45%) ) ÷ Shift Correction Factor \text{RI} = \text{Reticulocyte } \% \times \left( \frac{\text{Patient Hct}}{\text{Normal Hct (45\%)}} \right) \div \text{Shift Correction Factor} RI = Reticulocyte % × ( Normal Hct (45%) Patient Hct ​ ) ÷ Shift Correction Factor

A shift correction factor of 2.0 is applied if polychromasia (shift reticulocytes) is present or hematocrit is severely depressed (< 25%). An RI > 2% indicates robust bone marrow erythrocyte production in response to peripheral RBC destruction (hemolysis) or acute blood loss. An RI < 2% indicates an inadequate marrow response, pointing to hypoproliferative bone marrow failure, nutrient deficiency, or systemic suppression.

Microcytic Anemias (MCV < 80 fL)

Microcytic anemias stem from defective hemoglobin synthesis, involving either heme production (iron deficiency, sideroblastic anemia, lead toxicity, chronic disease) or globin chain synthesis (thalassemias).

Etiologies & Iron Panel Differentiation

Iron Deficiency Anemia (IDA) : The most common cause of anemia worldwide. Caused by chronic blood loss (gastrointestinal malignancy in older adults, menorrhagia in premenopausal women) or malabsorption (celiac disease, post-gastrectomy). Characterized by serum ferritin < 30 ng/mL, high Total Iron Binding Capacity (TIBC > 400 µg/dL), low transferrin saturation (< 15%), and an elevated Red Cell Distribution Width (RDW > 15%) reflecting anisocytosis.

Anemia of Chronic Disease / Inflammation (ACD/AI) : Driven by inflammatory cytokines (IL-6, TNF-alpha) that stimulate hepatic production of hepcidin . Hepcidin degrades ferroportin on enterocytes and macrophages, trapping iron within storage sites. Characterized by elevated serum ferritin (> 300 ng/mL), low TIBC (< 250 µg/dL), low serum iron, and low transferrin saturation (15–20%).

Thalassemias : Quantitative globin chain synthesis defects. Beta-thalassemia minor (heterozygous beta-gene mutation) presents with mild microcytic anemia (MCV often < 70 fL despite Hgb 10–11 g/dL), normal or elevated serum ferritin, normal RDW, and characteristic HbA2 > 3.5% (and elevated HbF) on hemoglobin electrophoresis. Alpha-thalassemia trait (two-gene deletion: --/alpha alpha or -alpha/-alpha) presents with microcytosis and normal hemoglobin electrophoresis in adults.

Sideroblastic Anemia : Defective heme synthesis leading to iron accumulation in erythrocyte mitochondria. Primary cause is X-linked ALAS2 mutation; acquired causes include alcohol toxicity , lead poisoning , and isoniazid (B6 deficiency) . Diagnosed by ringed sideroblasts (≥ 15% on Prussian blue bone marrow stain), high serum iron, high ferritin, and transferrin saturation > 50%.

Lead Toxicity : Inhibits delta-aminolevulinic acid dehydratase ( ALAD ) and ferrochelatase . Presents with abdominal colic, peripheral neuropathy (foot/wrist drop), basophilic stippling on blood smear, and elevated blood lead level (BLL ≥ 3.5 µg/dL in children, ≥ 5 µg/dL in adults).

  • Condition Serum Iron Serum Ferritin TIBC Transferrin Saturation RDW
  • Iron Deficiency Low (< 50 µg/dL) Low (< 30 ng/mL) High (> 400 µg/dL) Low (< 15%) High (> 15%)
  • Chronic Disease Low (< 50 µg/dL) High (> 300 ng/mL) Low (< 250 µg/dL) Low/Normal (15-20%) Normal (11.5-14.5%)
  • Beta-Thal Minor Normal/High Normal/High Normal Normal/High Normal (11.5-14.5%)
  • Sideroblastic High (> 150 µg/dL) High (> 300 ng/mL) Low/Normal High (> 50%) High (> 15%)
  • Diagnostic Algorithm: Microcytic Anemia [ Patient with Microcytic Anemia (MCV < 80 fL) ]
  • │
  • Measure Serum Ferritin & Iron Panel
  • │
  • ┌──────────────┼──────────────┐
  • ▼ ▼ ▼
  • Ferritin < 30 ng/mL Ferritin > 300 ng/mL Normal Ferritin / TIBC
  • │ │ │
  • ▼ ▼ ▼
  • Iron Deficiency Anemia of Chronic Hemoglobin Electrophoresis
  • (Check GI/GU Disease (ACD) ┌───────┴───────┐
  • bleeding sites) (Hepcidin-driven)▼ ▼
  • HbA2 > 3.5% Normal HbA2/HbF
  • │ │
  • ▼ ▼
  • Beta-Thal Alpha-Thal Trait
  • Minor or Lead/B6 evaluation
  • Normocytic Anemias (MCV 80–100 fL)

Normocytic anemias require immediate evaluation of the Reticulocyte Index (RI) to branch into hyperproliferative (RI > 2%) vs hypoproliferative (RI < 2%) categories.

Hyperproliferative (RI > 2%): Hemolytic Anemias & Hemorrhage

Intrinsic Hemolytic Anemias :

Hereditary Spherocytosis : Autosomal dominant defect in spectrin/ankyrin. Shows spherocytes on smear, positive osmotic fragility test , negative Direct Antiglobulin Test (DAT/Coombs), and elevated MCHC (> 36 g/dL) . Splenectomy is curative for severe anemia.

G6PD Deficiency : X-linked recessive enzymopathy predisposing RBCs to oxidative stress (fava beans, sulfa drugs, infections). Smear shows Heinz bodies (crystal violet stain) and bite cells .

Sickle Cell Disease (HbSS) : Glutamate to valine mutation at codon 6 of beta-globin chain. Presents with vaso-occlusive crises, acute chest syndrome (fever, chest pain, new infiltrate), and splenic autoinfarction by adulthood.

Paroxysmal Nocturnal Hemoglobinuria (PNH) : Acquired PIGA gene mutation causing loss of GPI-anchored proteins ( CD55 and CD59 ). Presents with nocturnal hemoglobinuria, severe thrombosis (hepatic vein / Budd-Chiari syndrome), and positive flow cytometry for CD55/CD59 deficiency.

Extrinsic Hemolytic Anemias :

Autoimmune Hemolytic Anemia (AIHA) :

Warm AIHA (IgG) : RBC destruction at 37°C in spleen. Associated with CLL, SLE, and drugs (penicillin, alpha-methyldopa). Positive IgG Direct Coombs test . Treated with corticosteroids.

Cold AIHA (IgM) : Complement-mediated RBC agglutination at < 37°C in acral areas. Associated with Mycoplasma pneumoniae and EBV. Positive C3 Direct Coombs test . Treated with cold avoidance; corticosteroids are ineffective.

Hypoproliferative (RI < 2%): Marrow Failure

Aplastic Anemia : Pancytopenia (Hgb < 10 g/dL, Platelets < 50,000/µL, ANC < 1,500/µL) with hypocellular marrow (> 70% fat spaces). Caused by drugs (carbamazepine, NSAIDs), viruses (parvovirus B19, EBV, hepatitis), or autoimmune destruction. Treated with bone marrow transplant or immunosuppression (cyclosporine + antithymocyte globulin).

Chronic Kidney Disease (CKD) : Decreased erythropoietin (EPO) synthesis by renal peritubular interstitial cells when eGFR drops < 30 mL/min/1.73 m². Treated with recombinant human EPO or darbepoetin after ensuring adequate iron stores.

Macrocytic Anemias (MCV > 100 fL)

Macrocytic anemias are subdivided based on peripheral blood smear evidence of megaloblastic maturation (hypersegmented neutrophils: ≥ 5 lobes in > 5% of PMNs or 1 PMN with ≥ 6 lobes).

Megaloblastic vs Non-Megaloblastic Etiologies

Megaloblastic Anemia (Impaired DNA Synthesis):

Vitamin B12 (Cobalamin) Deficiency : Caused by pernicious anemia (anti-intrinsic factor / anti-parietal cell antibodies), ileal resection, or strict vegan diet. Clinical findings include macrocytic anemia, glossitis, and subacute combined degeneration (SCD) of the spinal cord (posterior columns: loss of vibration/proprioception; lateral corticospinal tracts: spastic paraparesis). Lab testing reveals elevated serum homocysteine AND elevated methylmalonic acid (MMA > 0.4 µmol/L) .

Folate Deficiency : Caused by alcoholism, malnutrition, pregnancy, or antifolate drugs (methotrexate, trimethoprim, phenytoin). Clinical findings mirror B12 deficiency but lack neurologic deficits . Lab testing reveals elevated serum homocysteine with NORMAL methylmalonic acid .

Non-Megaloblastic Macrocytic Anemia (Normal DNA Synthesis):

Causes include chronic alcoholism (direct marrow toxicity), liver disease (lipid deposition on RBC membranes), hypothyroidism , and drugs such as hydroxyurea or AZT .